$IMLE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SOBR Safe, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SOBR Safe, Inc.. Get notifications about new insider transactions in SOBR Safe, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2021 | IMLE | SOBR Safe, Inc. | Bennington Charles Warren | Director | Sell | S | 3.20 | 1,000 | 3,200 | 456,958 | 458 K to 457 K (-0.22 %) |
Dec 31 2020 | IMLE | SOBR Safe, Inc. | Graham Gary John | 10% Owner | Buy | P | 0.00 | 2,743,169 | 0 | 17,846,197 | 15.1 M to 17.8 M (+18.16 %) |
Dec 31 2020 | IMLE | SOBR Safe, Inc. | Graham Gary John | 10% Owner | Buy | P | 1,551,510.00 | 3,103,028 | 4,814,391,384,392 | 15,103,028 | 12 M to 15.1 M (+25.86 %) |
Oct 01 2020 | IMLE | SOBR Safe, Inc. | Bennington Charles Warren | Secretary | Option Exercise | P | 0.26 | 24,053 | 6,336 | 24,053 | |
Oct 01 2020 | IMLE | SOBR Safe, Inc. | Bennington Charles Warren | Secretary | Buy | P | 9,656.03 | 6,832 | 65,969,997 | 457,958 | 451.1 K to 458 K (+1.51 %) |
Jun 23 2020 | IMLE | SOBR Safe, Inc. | Graham Gary John | Director | Option Exercise | A | 0.50 | 320,000 | 160,000 | 12,320,000 | |
Jun 23 2020 | IMLE | SOBR Safe, Inc. | Graham Gary John | Director | Grant | A | 0.00 | 12,000,000 | 0 | 12,000,000 | 0 to 12 M |
Jan 16 2020 | IMLE | TransBiotec, Inc. | Gandini David Joseph | Chief Revenue Offic ... | Option Exercise | A | 0.01 | 24,000,000 | 189,600 | 32,000,000 | |
Jan 16 2020 | IMLE | TransBiotec, Inc. | Gandini David Joseph | Chief Revenue Offic ... | Option Exercise | A | 0.01 | 8,000,000 | 63,200 | 8,000,000 | |
Jan 16 2020 | IMLE | TransBiotec, Inc. | Moore Kevin D | Chief Executive Off ... | Option Exercise | A | 0.01 | 35,200,000 | 278,080 | 35,200,000 | |
Jan 16 2020 | IMLE | TransBiotec, Inc. | Moore Kevin D | Chief Executive Off ... | Grant | A | 0.00 | 800,000 | 0 | 2,400,000 | 1.6 M to 2.4 M (+50.00 %) |
Jan 16 2020 | IMLE | TransBiotec, Inc. | Moore Kevin D | Chief Executive Off ... | Grant | A | 0.00 | 800,000 | 0 | 1,600,000 | 800 K to 1.6 M (+100.00 %) |
Jan 16 2020 | IMLE | TransBiotec, Inc. | Moore Kevin D | Chief Executive Off ... | Grant | A | 0.00 | 800,000 | 0 | 800,000 | 0 to 800 K |
Sep 18 2019 | IMLE | TransBiotec, Inc. | Mishal Devadatt M | Director | Buy | P | 0.00 | 13,134,420 | 53,851 | 20,534,857 | 7.4 M to 20.5 M (+177.48 %) |
Sep 17 2019 | IMLE | TransBiotec, Inc. | Lanphere Michael A. | V.P. of Legal Affai ... | Buy | P | 0.00 | 21,400,745 | 96,303 | 71,545,623 | 50.1 M to 71.5 M (+42.68 %) |
Sep 17 2019 | IMLE | TransBiotec, Inc. | Lanphere Michael A. | V.P. of Legal Affai ... | Buy | P | 0.10 | 5,206,430 | 520,643 | 50,144,878 | 44.9 M to 50.1 M (+11.59 %) |
Sep 13 2019 | IMLE | TransBiotec, Inc. | Bennington Charles Warren | CEO, President and ... | Buy | P | 0.04 | 14,000,000 | 595,000 | 15,004,422 | 1 M to 15 M (+1,393.84 %) |
Page: 1